Ergotism associated with HIV antiviral protease inhibitor therapy

Journal of Vascular Surgery

Volumn 37, Issue 3, 2003, Pages 676-678

  Baldwin, Zachary K ^a   Ceraldi, Chris C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; ANTICOAGULANT AGENT; ANTIFUNGAL AGENT; ANTIRETROVIRUS AGENT; AZITHROMYCIN; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOCHROME P450 3A4; DAUNORUBICIN; DILTIAZEM; ERGOT ALKALOID; ERGOTAMINE TARTRATE; ERYTHROMYCIN; HEPARIN DERIVATIVE; INDINAVIR; ITRACONAZOLE; KETOCONAZOLE; MACROLIDE; NEFAZODONE; NELFINAVIR; NIFEDIPINE; NUCLEOSIDE DERIVATIVE; PREDNISONE; PROTEINASE INHIBITOR; RITONAVIR; VINCRISTINE SULFATE; WARFARIN;

ADULT; ANTICOAGULATION; ARTERIOGRAPHY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; COLOR ULTRASOUND FLOWMETRY; CYANOSIS; DEEP VEIN THROMBOSIS; ENZYME INHIBITION; ERGOTISM; HEPARINIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOMA; MALE; MIGRAINE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TOXICITY; TREATMENT OUTCOME; VASOSPASM;

EID: 0037344309     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2003.80     Document Type: Article

References (21)

1. Garcia G, Goff J, Hadro N, O'Donnell S, Greatorex P. Chronic ergot toxicity: A rare cause of lower extremity ischemia. J Vasc Surg 2000;31: 1245-7.
2. Reynolds J. Martindale: The extra Pharmacopoeia. London: Royal Pharmaceutical Society; 1996. p 481-3.
3. Dresser G, Spence J, Bailey D. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P-450 3A4 inhibition. Clin Pharmacokinet 2000;38:41-57.
4. Kumar GN, Rodrigues AD, Buko AM, Denisien IF. Cytochrome P-450 mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes. J Pharmacol Exp Ther 1996;227:423-31.
5. Mortier E, Pouchot J, Vinceneux P, Lalande M. Ergotism related to interaction between nelfinavir and ergotamine. Am J Med 2001;110: 594.
6. Vila A, Mykietiuk A, Bonvehi P, Temporiti E, Uruena A, Herrera F. Clinical ergotism induced by ritonavir. Scand J Infect Dis 2001;33: 788-9.
7. Blanche P, Rigolet A, Gombert B, Ginsburg C, Salmon D, Sicard D. Ergotism related to a single dose of ergotamine tartrate in an AIDS patient treated with ritonavir. Postgrad Med J 1999;75:546-7.
8. Rosenthal E, Sala F, Chichmanian R, Batt M, Cassuto J. Ergotism related to concurrent administration of ergotamine tartrate and indinivir. JAMA 1999;281:11.
9. Liaudet L, Buclin T, Jaccard C, Eckert P. Drug points: Severe ergotism associated with interaction between ritonavir and ergotamine. BMJ 1999;318:771.
10. Caballero-Granado F, Vicana P, Cordero E, Gomez-Vera M, del Nozal M, Lopez-Cortes L. Ergotism related to concurrent administration of ergotamine tartrate and ritonavir in an AIDS patient. Antimicrob Agents Chemother 1997;41:1207.
11. Montero A, Giovannoni AG, Tvrde PL. Leg ischemia in a patient receiving ritonavir and ergotamine [letter]. Ann Intern Med 1999;130: 329-30.
12. Phan T, Agaliotis D, White G, Britton W. Ischaemic peripheral neuritis secondary to ergotism associated with ritonavir therapy. Med J Aust 1999;171:502.
13. Spiegel M, Schmidauer C, Kampfl A, Sarcletti M, Poewe W. Cerebral ergotism under treatment with ergotamine and ritonavir. Neurology 2001;57:743-4.
14. Cameron EA, French EB. St Anthony's fire rekindled: Gangrene due to therapeutic doses of ergotamine. BMJ 1960;2:28-30.
15. Wells K, Steed D, Zajko A, Webster M. Recognition and treatment of arterial insufficiency from Cafergot. J Vasc Surg 1986;4:8-15.
16. Senter J, Lieverman A, Pinto R. Cerebral manifestations of ergotism: Report of a case and review of the literature. Stroke 1976;7:88-92.
17. McKieman T, Bock K, Leya F, Grassman E, Lewis B, Johnson SA, et al. Ergot induced peripheral vascular insufficiency: Non-interventional treatment. Cathet Cardiovasc Diagn 1994;31:211-4.
18. Horowitz R, Dart R, Gomez H. Clinical ergotism with lingual ischemia induced by clarithromycin-ergotamine interaction. Arch Intern Med 1996;156:456-8.
19. Ausband S, Goodman P. An unusual case of clarithromycin-associated ergotism. J Emerg Med 2001;21:411-3.
20. Ghali R, De Lean J, Doubille Y, Noel HP, Labbe R. Erythromycin associated ergotamine intoxication: Arteriographic and electrophysiologic analysis of a rare cause of severe ischemia of the lower extremities and associated ischemic neuropathy. Ann Vasc Surg 1993;7:291-51.
21. Goldfrank L, et al. Toxicologic emergencies. Norwalk, Conn: Appleton & Lange; 1994. P 647-51.